Navigation Links
The Wisconsin Heart Hospital Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery
Date:1/11/2008

video footage that shows a robotic closed-chest bypass procedure using the C-Port Flex A system in combination with the da Vinci(R) Surgical System. To date, Dr. Brunsting has performed several closed chest procedures using the Cardica device.

Moderating the live procedure will be Tung Cai, M.D., Medical Director and Chief of Cardiothoracic Surgery at the Presbyterian Hospital of Denton. Dr Cai will present his published clinical patency data on the C-Port distal portfolio and review Dr. Balkhy's C-Port patency data from the November 2007 American Heart Association Scientific conference. This data was part of a study co-authored with Samuel Wann, M.D., Chair of the Department of Cardiac and Vascular Medicine at The Wisconsin Heart Hospital.

All three physicians will narrate during the procedure, explaining critical aspects of the surgery, and will answer viewers' e-mail questions submitted live during the event.

"This particular type of bypass is vital to the development of robotic, closed-chest bypass procedures, and therefore proving its efficacy in open-chest procedures is critical," said Dr. Balkhy.

According to Dr. Balkhy, "Cardica's C-Port systems represent a breakthrough in distal anastomotic devices that facilitate and simplify beating heart and robotic CABG procedures. These devices allow surgeons to offer patients less invasive cardiac surgery and may improve outcomes. This live webcast will provide surgeons with a convenient forum for an interactive exchange of questions, ideas and opinions about these revolutionary devices."

"The C-Port Flex A system has the potential to revolutionize the field of cardiothoracic surgery, as it may enable closed-chest, robot-assisted CABG procedures to be more reliably performed without the assistance of cardiopulmonary bypass and cardioplegic arrest of the heart," added Dr. Brunsting.

About The Wisconsin Heart Hospital

Located in Wauwatosa, Wisconsin, The Wisconsin Heart H
'/>"/>

SOURCE The Wisconsin Heart Hospital
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. New Drug Application for Tolvaptan, Otsukas Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia, Accepted by the U.S. Food and Drug Administration
2. Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure
3. New Cardiology Software Helps Heart Centers Manage for Optimal Clinical Performance
4. Berlin Heart Enrolls First Patient in US Multi-Center EXCOR(R) Pediatric VAD IDE Study
5. WorldHeart Schedules Teleconference
6. Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington
7. Presentation of Phase IIa Results for Cytos Biotechnologys Hypertension Vaccine at the American Heart Association Scientific Sessions 2007
8. Reverse Cholesterol Transport by RVX-208 a Small Molecule for ApoA-I Production Increase Presented at American Heart Association Scientific Meeting
9. ALOKA to Introduce New ProSound Diagnostic Ultrasound Systems at the Scientific Session 2007 of American Heart Association, 4th to 7th of November 2007 in Orlando, Florida
10. CV Therapeutics Announces Presentations at American Heart Association Scientific Sessions 2007
11. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2014)... NY (PRWEB) July 26, 2014 ... provides key market data on the Canada Endoscopy ... millions of US dollars, volume (in units) and ... - High-End Endoscopy Visualization Systems, Mid-Range Endoscopy Visualization ... Full Report at http://www.marketresearchreports.biz/analysis/213254 . , The ...
(Date:7/25/2014)... 26, 2014 "Ischemic Stroke and ... provides data on the Ischemic Stroke and Cerebral ... information and data relating to the clinical trials ... full global Ischemic Stroke Research Report 2014 at: ... of the trial numbers and their recruitment status ...
(Date:7/25/2014)... , July 25, 2014 Amgen (NASDAQ: ... today declared a $0.61 per share dividend for the ... on Sept. 5, 2014, to all stockholders of record ... 2014.  About Amgen Amgen is committed ... from serious illnesses by discovering, developing, manufacturing and delivering ...
(Date:7/25/2014)... bacteria live in each person,s digestive tract. Scientists believe ... stave off harmful infections, but their role in human ... light on the role of these bacteria, a team ... recently tracked fluctuations in the bacterial populations of two ... in the July 25 issue of the journal ...
Breaking Biology Technology:Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 3Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 5Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 2Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 3Amgen Announces 2014 Third Quarter Dividend 2Amgen Announces 2014 Third Quarter Dividend 3Monitoring the rise and fall of the microbiome 2Monitoring the rise and fall of the microbiome 3
... BioMarin Pharmaceutical,Inc. (Nasdaq: BMRN ) today announced that ... update at the Piper,Jaffray Healthcare Conference in New York City ... Interested parties may access a ... of the BioMarin website, http://www.BMRN.com . A,replay of the ...
... Germany, November 25 t2cure, a,biopharmaceutical company developing ... today announced that it has acquired a family ... transfer arm,of Frankfurt University. , ... that allows for the rapid characterization,of the potency ...
... Genoptix, Inc. (Nasdaq: GXDX ), a specialized laboratory services ... Jaffray Healthcare Conference scheduled to take place at the New York ... , , Dr. Tina S. ... on Wednesday, December 3, beginning at approximately 2:00 p.m. EST. ...
Cached Biology Technology:BioMarin to Present at the Piper Jaffray Healthcare Conference 2t2cure Acquires Patent Family on In Vitro Potency Testing of Stem Cells for Cardiovascular Application 2Genoptix Announces Participation at the Twentieth Annual Piper Jaffray Healthcare Conference 2
(Date:7/24/2014)... The University of Texas Health Science Center at Houston ... help Harris County residents whose vision problems cannot be ... corrective lenses, many people with low vision can see ... low vision devices, such as telescopes, magnifiers and electronic ... is using the three-year, $164,645 SightFirst grant from the ...
(Date:7/24/2014)... week for an all-day public forum on a $1.7 ... to dredge toxic sediment from an eight-mile stretch of ... the plan, which proposes removing 4.3 million cubic yards ... one of the largest cleanups in the agency,s history. ... , "We need to ensure the future well-being of ...
(Date:7/24/2014)... hazard in the United States, wildland managers often utilize ... suppressed trees (ladder fuels). These cuttings and other ... fire danger in order to dispose of the material. ... managers often cover all or part of the debris ... agricultural plastic, in order to keep water out. A ...
Breaking Biology News(10 mins):UTHealth Dr. Bhavani Iyer awarded low vision grant 2Experts Weigh the Pros and Cons of a $1.7 Billion EPA Cleanup Plan for the Passaic River at an NJIT 2Study gives new perspective on agricultural plastic, debris burning, and air quality 2
... hold great promise for benefiting degenerative diseases, and do ... grown in a manner compatible with clinical use (i.e., ... for immunosuppression. These were a few of a number ... by Evan Y. Snyder, M.D., Ph.D., and spearheaded by ...
... from another may depend on the number of receptors ... of receptors is controlled by levels of a ubiquitous ... found. , Everything from the ability to concentrate, perceive ... sclerosis, muscular dystrophy, post-traumatic stress syndrome and schizophrenia is ...
... launch of the first large-scale study to evaluate a ... today by study collaborators in the United States and ... participants at five sites throughout South Africa and is ... are part of the HIV Vaccine Trials Network (HVTN), ...
Cached Biology News:Stem cells act through multiple mechanisms to benefit mice with neurodegenerative disease 2Stem cells act through multiple mechanisms to benefit mice with neurodegenerative disease 3Stem cells act through multiple mechanisms to benefit mice with neurodegenerative disease 4Stem cells act through multiple mechanisms to benefit mice with neurodegenerative disease 5Bisexual fruit flies show new role for neurochemical 2Africa's first large-scale HIV vaccine study launches 2Africa's first large-scale HIV vaccine study launches 3Africa's first large-scale HIV vaccine study launches 4
MAb to Yersinia pestis F1 Ag. Yersinia pestis F1 Antigen EB Strain...
Mouse monoclonal antibody to QDPR - quinoid dihydropteridine reductase...
... Chromogen System consists of FAST RED chromogen,tablets ... the presence of alkaline phosphatase to produce ... The FAST RED System provides enough material ... , , Vial A: 6 Tablets , ...
The BioLogic Maximizer mixer is for use with the Maximizer valve system. The mixer improves gradient quality by mixing the output of the BioLogic DuoFlow workstation pumps....
Biology Products: